Developing a new and potent anti-K-RAS strategy by inhibiting SIAH E3 ligase, the most downstream "gatekeeper" in the oncogenic K-RAS signal pathway, to block well-established pancreatic tumor growth Meeting Abstract

authors

publication date

  • July 1, 2015

webpage

published in

volume

  • 75